TruLaw partners with pharmaceutical litigation leaders who possess deep knowledge of FDA regulatory requirements and product liability law, ensuring clients receive representation from attorneys who can effectively evaluate eligibility and build strong cases based on these legal theories
GLP-1 receptor agonist drugs replicate these actions and induce satiety and delay gastric emptying that may cause a lowered caloric intake and weight reduction
Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial
For example, a population-based cohort study in obese individuals without diabetes reported a fourfold increase in intestinal obstruction risk associated with GLP-1 RA use
Doctor-Designed Nutrition for GLP-1 Users (15 Servings / 30 Scoops): Created for women and men using GLP-1 medications, this daily nutritional shake helps support balanced nutrition during reduced food intake
Zepbound is a brand-name tirzepatide medication that may be considered for chronic weight management in eligible patients when clinically appropriate
